Medicenna Presents Preclinical IL-13 Superkine Data at the AACR Annual Meeting
— IL-13 Superkines provide a versatile strategy for targeted delivery of anti-cancer agents to IL-13Rα2,…
Year: 2023
Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
PHILADELPHIA, April 17, 2023 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative clinical-stage biotechnology…
Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
PHILADELPHIA, April 17, 2023 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative clinical-stage biotechnology…
Forward-thinking partnership brings new cannabis-infused iced tea to Québec
ROSE LifeScience, Entourage Health Corp. and The Boston Beer Company collaborate for innovative launch HUNTINGDON,…
Forward-thinking partnership brings new cannabis-infused iced tea to Québec
ROSE LifeScience, Entourage Health Corp. and The Boston Beer Company collaborate for innovative launch HUNTINGDON,…
Aflibercept 8 mg and EYLEA® (aflibercept) Injection Presentations at ARVO Provide New Insights into the Treatment of Serious Retinal Diseases
New subgroup data and further analyses of the aflibercept 8 mg clinical trial program to…
Aflibercept 8 mg and EYLEA® (aflibercept) Injection Presentations at ARVO Provide New Insights into the Treatment of Serious Retinal Diseases
New subgroup data and further analyses of the aflibercept 8 mg clinical trial program to…
Gritstone bio Presents Advances in Neoantigen Prediction and Cancer Vaccine Immunogenicity at the 2023 AACR Annual Meeting
— Longitudinal analysis of GRANITE recipients (personalized vaccine candidate now in Phase 2/3 for MSS-CRC)…
Gritstone bio Presents Advances in Neoantigen Prediction and Cancer Vaccine Immunogenicity at the 2023 AACR Annual Meeting
— Longitudinal analysis of GRANITE recipients (personalized vaccine candidate now in Phase 2/3 for MSS-CRC)…
Tonix Pharmaceuticals Announces Two Publications of Data in American Journal of Transplantation Showing TNX-1500 (anti-CD40L mAb) Prolongs Nonhuman Primate Renal and Heart Allograft Survival
Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General Hospital CHATHAM, N.J.,…
Tonix Pharmaceuticals Announces Two Publications of Data in American Journal of Transplantation Showing TNX-1500 (anti-CD40L mAb) Prolongs Nonhuman Primate Renal and Heart Allograft Survival
Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General Hospital CHATHAM, N.J.,…
Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O’Connor to Company’s Board of Directors
DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O’Connor to Company’s Board of Directors
DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
Apellis Partners with Acclaimed Actor Henry Winkler to Raise Awareness of Geographic Atrophy (GA) for the GA Won’t Wait™ Campaign
GA is an advanced form of age-related macular degeneration (AMD) and a leading cause of…
Apellis Partners with Acclaimed Actor Henry Winkler to Raise Awareness of Geographic Atrophy (GA) for the GA Won’t Wait™ Campaign
GA is an advanced form of age-related macular degeneration (AMD) and a leading cause of…
ONCOTELIC PROVIDES YE 2022 FINANCIAL RESULTS COMPARED TO YE 2021 PRODUCT DEVELOPMENT INITIATIVES AND CORPORATE UPDATE
AGOURA HILLS, Calif., April 17, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic”, “We” or…
TeleVox Launches AI-Enabled Omnichannel Conversational Virtual Assistant for Healthcare Providers
Iris™ improves patient access, reduces staff burden, and boosts revenue CHICAGO, April 17, 2023 (GLOBE…
Illumio Launches Zero Trust Segmentation ROI Calculator to Help Organizations Maximize Cyber Investments
Illumio ZTS platform delivered 111 percent return on investment and 66 percent reduction in blast…
Illumio Launches Zero Trust Segmentation ROI Calculator to Help Organizations Maximize Cyber Investments
Illumio ZTS platform delivered 111 percent return on investment and 66 percent reduction in blast…
WideOrbit Announces Next-Generation Cross-Media, Browser-Based Ad Sales Solution Enabling Smarter Selling from Anywhere
WO Fusion is the company’s next-generation media sales product, focused on cross-media, multi-market ad sales…